TokenPost·
Dr. Reddy’s Targets November Relaunch of Generic Semaglutide
6-7M
device target FY27
Validation results remain pending; the company reiterated a target of 6 million to 7 million devices for FY27.
More news
- TokenPostEthereum Wallet Keyed to 6969 Drew Three Pending Transactions
- CoinDeskArgentina drops criminal probe into President Milei over crashed memecoin LIBRA
- TokenPostAI Spending Concerns Weigh on U.S. Tech Stocks as Iran Risks Rise
- TokenPostPhantom’s U.S. Kalshi Markets Charge 2 Cents in Trading Fees per Contract
- CryptoPotatoBitcoin Price Suddenly Dumps Below $80K as Liquidations Surge to $670M
- TokenPostMoonbirds Leads Crypto Search Rankings as Irys Jumps 313.41%